Imperial Brands (AO) | Buy | Black Buffalo acquisition: Broadening US Oral Exposure

Research evidence excerpt

Imperial Brands (AO) | Buy | Black Buffalo acquisition: Broadening US Oral Exposure

aight, Blood Orange and Peach, alongside nicotine-free variants and sampler packs.

This looks like a strategically logical bolt-on that deepens Imperial’s US oral exposure without changing its broader NGP playbook. The

company is clearly reinforcing oral as its preferred US reduced-risk category, rather than pivoting back into US vape. Black Buffalo

broadens the portfolio into a product format designed to appeal to adult MST users, which is distinct from Zone’s more conventional

flavoured pouch positioning. That should give Imperial a broader oral architecture across different usage occasions and consumer

segments.

The commercial logic is also straightforward: Black Buffalo brings a differentiated brand and established retail footprint, while Imperial

contributes national sales execution, retailer relationships and distribution scale. In practice, the deal looks less about acquiring new

capability and more about accelerating scale through Imperial’s existing US infrastructure. That is consistent with what the company has

been signalling recently around disciplined, focused NGP investment.

From a financial perspective, the initial outlay looks manageable relative to Imperial’s balance sheet and cash generation, and the

deferred consideration structure suggests part of the valuation is linked to delivery. Just as importantly, Imperial explicitly says the deal

is consistent with its bolt-on M&A framework and reiterates its commitment to the ongoing share buyback programme, which should

help reassure investors that this is not a shift away from shareholder returns.

The key strategic implication is that Imperial is now building a more complete US oral platform.